Abstract

BackgroundNa/K-ATPase (NKA) is inhibited by perillyl alcohol (POH), a monoterpene used in the treatment of tumors, including brain tumors. The NKA α1 subunit is known to be superexpressed in glioblastoma cells (GBM). This isoform is embedded in caveolar structures and is probably responsible for the signaling properties of NKA during apoptosis. In this work, we showed that POH acts in signaling cascades associated with NKA that control cell proliferation and/or cellular death.MethodsNKA activity was measured by the amount of non-radioactive Rb+ incorporation into cultured GBM cell lines (U87 and U251) and non-tumor cells (mouse astrocytes and VERO cells). Cell viability was measured by lactate dehydrogenase levels in the supernatants of POH-treated cells. Activated c-Jun N-terminal Kinase (JNK) and p38 were assessed by western blotting. Apoptosis was detected by flow cytometry and immunocytochemistry, and the release of interleukins was measured by ELISA.ResultsAll four cell types tested showed a similar sensitivity for POH. Perillic acid (PA), the main metabolite of POH, did not show any effect on these cells. Though the cell viability decreased in a dose-dependent manner when cells were treated with POH, the maximum cytotoxic effect of PA obtained was 30% at 4 mM. 1.5 mM POH activated p38 in U87 cells and JNK in both U87 and U251 cells as well as mouse astrocytes. Dasatinib (an inhibitor of the Src kinase family) and methyl β-cyclodextrin (which promotes cholesterol depletion in cell membranes) reduced the POH-induced activation of JNK1/2 in U87 cells, indicating that the NKA-Src complex participates in this mechanism. Inhibition of JNK1/2 by the JNK inhibitor V reduced the apoptosis of GBM cells that resulted from POH administration, indicating the involvement of JNK1/2 in programmed cell death. 1.5 mM POH increased the production of interleukin IL-8 in the U251 cell supernatant, which may indicate a possible strategy by which cells avoid the cytotoxic effects of POH.ConclusionsA signaling mechanism mediated by NKA may have an important role in the anti-tumor action of POH in GBM cells.Electronic supplementary materialThe online version of this article (doi:10.1186/s12943-015-0374-5) contains supplementary material, which is available to authorized users.

Highlights

  • Na/K-ATPase (NKA) is inhibited by perillyl alcohol (POH), a monoterpene used in the treatment of tumors, including brain tumors

  • As a first step in studying the ability of POH to inhibit glioma cell proliferation, we evaluated the NKA activity based on the incorporation of Rb+ by tumor and nontumor cells

  • Together, our data lead to the following proposed mechanism for the action of POH in tumor glial cells (Figure 10): the connection between POH and NKA present in the signalosome could stimulate the Src kinase, leading to signaling via the mitogen-activated protein kinase family (MAPKs) signaling cascade and subsequent activation of Jun N-terminal Kinase (JNK) and p38

Read more

Summary

Introduction

Na/K-ATPase (NKA) is inhibited by perillyl alcohol (POH), a monoterpene used in the treatment of tumors, including brain tumors. Apart from its function as an ion pump, NKA is a signal transducer This enzyme interacts with different signaling proteins in caveolae, including Src tyrosine kinase, PKC, PKA, PI3K, caveolins and EGFR [4,5,6,7,8]. This set of proteins associated with NKA is called the signaling complex or signalosome, which is restricted to caveolae [5,7,8,9,10,11,12]. The intracellular signaling triggered by cardiac glycosides depends on the cell type, exposure time and drug concentration [14,15]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call